Elina Yamada MD

Assistant Professor, Cardiology
Specialties: 
Internal Medicine, Cardiology
Clinical Interests:

Dr. Yamada has been practicing Medicine and Cardiology over 20 years. She has expertise in Echocardiography which has allowed her to better understand, diagnose and treat cardiac disease. Her clinical and research interests include: the relationship between cancer treatment and heart disease; the role of Echocardiography to understand different cardiac pathologies and treatment; mitral valve disease; and atrial fibrillation. Dr. Yamada launched the Cardio-Oncology clinic at the UMHS Cardiovascular Center in 2011, after a period of training at the MD Anderson Cancer Center. In this clinic, she evaluates patients who has cancer and is either at risk, or developed cardiac disease as complication of cancer treatment. Her goal in this clinic is to prevent, early diagnose and treat cardiac toxicity from cancer treatment, and to optimize underlying heart condition prior to cancer therapy. Dr. Yamada is also interested in helping the Childhood Cancer Survivors to prevent heart complications from cancer treatment.

Locations

U of M Cardiology

Domino's Farms Lobby A
24 Frank Lloyd Wright Dr
Ann Arbor
MI
48105
Phone:
734-998-7400

U of M Cardiology

Cardiovascular Center Floor 3
1500 E Medical Center Dr SPC 5856
Ann Arbor
MI
48109
Phone:
888-287-1082
Fax:
734-232-4505

Credentials

Medical School or Training

  • Universidade De Sao Paulo, 1986

Residency

  • University of Iowa Hospitals and Clinics, Internal Medicine, IA, 2001

Fellowship

  • Echocardiography, Cleveland Clinic Hospital, 1998

  • Internal Medicine Cardiology, University of Michigan Health System, 2003

Professional Organizations

  • Fellow of the American College of Cardiology (FACC)

  • Fellow of the American Society of Echocardiography (FASE)

Board Certification

  • Cardiovascular Disease

Research

Dr Yamada is researching into the role of Global Myocardial Strain Imaging, a new modality in Echocardiography; and biomarkers in the early detection of damage to the heart from different cancer treatment drugs.